WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation

NCT01334060 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Leukaemia (Acute)
Leukaemia (Chronic)
Leukaemia (Acute Myeloid)
Leukaemia (Acute Lymphoblastic)
Leukaemia (Acute Promyelocytic)

Interventions

BIOLOGICAL: p.DOM-WT1-37 DNA Vaccine and p.DOM-WT1-126 DNA Vaccine

Sponsor

University Hospital Southampton NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]